Mabvax Therapeutics Holdings Stock Fundamentals
MabVax Therapeutics Holdings fundamentals help investors to digest information that contributes to MabVax Therapeutics' financial success or failures. It also enables traders to predict the movement of MabVax Pink Sheet. The fundamental analysis module provides a way to measure MabVax Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MabVax Therapeutics pink sheet.
MabVax |
MabVax Therapeutics Holdings Company Return On Asset Analysis
MabVax Therapeutics' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current MabVax Therapeutics Return On Asset | -61.26 |
Most of MabVax Therapeutics' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MabVax Therapeutics Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, MabVax Therapeutics Holdings has a Return On Asset of -61.26. This is much higher than that of the Healthcare sector and 159.58% higher than that of the Biotechnology industry. The return on asset for all United States stocks is notably higher than that of the company.
MabVax Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining MabVax Therapeutics's current stock value. Our valuation model uses many indicators to compare MabVax Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MabVax Therapeutics competition to find correlations between indicators driving MabVax Therapeutics's intrinsic value. More Info.MabVax Therapeutics Holdings is considered to be number one stock in return on equity category among related companies. It is considered to be number one stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value MabVax Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for MabVax Therapeutics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MabVax Therapeutics' earnings, one of the primary drivers of an investment's value.MabVax Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MabVax Therapeutics' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of MabVax Therapeutics could also be used in its relative valuation, which is a method of valuing MabVax Therapeutics by comparing valuation metrics of similar companies.MabVax Therapeutics is currently under evaluation in return on asset category among related companies.
MabVax Fundamentals
| Return On Equity | -819.66 | |||
| Return On Asset | -61.26 | |||
| Profit Margin | (223.49) % | |||
| Operating Margin | (208.49) % | |||
| Current Valuation | 4.11 M | |||
| Shares Outstanding | 9.25 M | |||
| Shares Owned By Insiders | 9.09 % | |||
| Shares Owned By Institutions | 1.79 % | |||
| Number Of Shares Shorted | 296.46 K | |||
| Price To Earning | (0.16) X | |||
| Price To Book | 63.90 X | |||
| Price To Sales | 0.50 X | |||
| Revenue | 4.7 M | |||
| Gross Profit | (7.54 M) | |||
| EBITDA | (9.64 M) | |||
| Net Income | (17.3 M) | |||
| Cash And Equivalents | 951.75 K | |||
| Cash Per Share | 0.10 X | |||
| Total Debt | 2.69 M | |||
| Current Ratio | 0.19 X | |||
| Cash Flow From Operations | (4.91 M) | |||
| Short Ratio | 1.94 X | |||
| Earnings Per Share | (2.05) X | |||
| Beta | 7.05 | |||
| Market Capitalization | 1.02 M | |||
| Total Asset | 15.1 M | |||
| Retained Earnings | (60.6 M) | |||
| Working Capital | 3.14 M | |||
| Current Asset | 7.44 M | |||
| Current Liabilities | 4.29 M | |||
| Z Score | -5.6 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in MabVax Pink Sheet
If you are still planning to invest in MabVax Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MabVax Therapeutics' history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |